A Randomized Trial of Intensive Lipid-Lowering Therapy in Calcific Aortic Stenosis

Cited by (1,000)

Items 801–900 of 1,000

  1. Genpolymorphismus bei der verkalkten Aortenklappenstenose
    Thomas Anger, Arif Bülent Ekici, Werner G. Daniel, Christoph D. Garlichs · 2006 · Herz
  2. Observational and Genetic Associations of Resting Heart Rate With Aortic Valve Calcium
    Seamus Paul Whelton, Andreas C. Mauer, Karol Mateusz Pencina, Joseph M. Massaro, Ralph B. D’Agostino, Caroline S. Fox, Udo Hoffmann, Erin D. Michos, Gina Marie Peloso, Line Dufresne et al. · 2018 · The American Journal of Cardiology
  3. Immunological considerations for heart valve replacements
    Hamza Atcha, Wendy F. Liu · 2019 · Elsevier eBooks
  4. Aortenklappenersatz bei älteren Patienten mit schwerer Aortenstenose
    , · 2010 · Cardiovascular Medicine
  5. Progression of calcifications in breast arteries in women at high risk for coronary heart disease events.
    A H E M Maas, Yvonne T. van der Schouw, Willem P.Th.M. Mali, Yolanda van der Graaf · 2006 · PubMed Central
  6. Multimodality imaging for the diagnosis and assessment of aortic stenosis severity
    Laurent Davin, Raluca Dulgheru, Anne Bernard, Stella Marchetta, Luc Piérard, Patrizio Lancellotti · 2016 · Expert Review of Cardiovascular Therapy
  7. Synopsis of Adult Cardiac Surgical Disease
    Robert M. Bojar · 2005 · Wiley eBooks
  8. Chapter 93. Vascular Calcification
    Dwight A. Towler, Linda L. Demer · 2008 · Wiley eBooks
  9. Aortic valve stenosis
    John R Kapoor, Roger Kapoor · 2009 · The Lancet
  10. Lipid lowering and aortic valve disease
    ANDERS G. OLSSON · 2009 · Current Atherosclerosis Reports
  11. Transcatheter aortic valve implantation: revolution and evolution 10 years on
    Aung Myat, David Hildick‐Smith, Christopher Young, Martyn Thomas, Simon Robert Redwood · 2012 · Heart
  12. Statins and Aortic Stenosis in the Context of Ratio of Low- to High-Density Lipoprotein Cholesterol
    Mehmet Birhan Yılmaz · 2007 · Journal of the American College of Cardiology
  13. Lp(a) Oxyphospholipids
    Dwight A. Towler · 2019 · Journal of the American College of Cardiology
  14. Lipid levels linked to symptomatic aortic valve stenosis: evidence from Mendelian randomization?
    Christoph Anton Nienaber, Xun Yuan · 2020 · European Heart Journal
  15. Editorial commentary: Lp(a) and calcific aortic valve stenosis: Direct LPA targeting or PCSK9-Lowering therapy?
    Romain Capoulade, Bertrand Cariou · 2020 · Trends in Cardiovascular Medicine
  16. Genetic proxy of lipid-lowering drugs and calcific aortic valve stenosis: A Mendelian randomization study
    Hou, Yucheng, Zhao, Jingwei, Xu, Wanchuang, Chen, Lei, Yang, Jingyue, Wang, Ziheng, Si, Ke · 2024 · Heliyon
  17. Association between evolocumab use and slow progression of aortic valve stenosis
    Kengo Terasaka, Masaomi Gohbara, Takeru Abe, Tomohiro Yoshii, Yohei Hanajima, Jin Kirigaya, Mutsuo Horii, Shinnosuke Kikuchi, Hidefumi Nakahashi, Kensuke Matsushita et al. · 2024 · Heart and Vessels
  18. The predictive value of serum lipoprotein(a) level for new-onset aortic valve calcification in patients with coronary artery disease
    Yao Ren, Yuying Deng · 2025 · BMC Cardiovascular Disorders
  19. Impact of Triglycerides and Remnant Particles on Hemodynamic Valve Deterioration After Transcatheter Aortic Valve Replacement
    Revathy Sampath-Kumar, Erika Padilla, Michael J. Wilkinson, David Torres Barba, Niki Aramburo, Ehtisham Mahmud, Ori Ben‐Yehuda, Pam R. Taub · 2025 · JACC Advances
  20. The Pursuit of Truth: Revisiting Causation Versus Association in Contemporary Cardiovascular Research
    Jonathan Laurence Ciofani, Usaid Khalil Allahwala, Avedis Assadour Ekmejian, Salvatore Pepe, Ravinay Bhindi · 2025 · Heart Lung and Circulation
  21. Cyclic guanosine monophosphate-protein kinase G signaling attenuates aortic valve calcification through ULK1-mediated autophagy
    Yan Wang, Fei Xu, Chengxiang Song, Xi Wang, Hao Zhou, Tianyi Qu, Hongde Li, Qiang Luo, Wenhua Lei, Yue Yin et al. · 2026 · Signal Transduction and Targeted Therapy
  22. Association of Polygenic Risk Scores With Aortic Valve Calcium: The Multi‐Ethnic Study of Atherosclerosis
    Seamus Paul Whelton, Jie Yao, Clary B. Clish, Alexis C. Wood, Kent D. Taylor, Michael Joseph Blaha, Matthew Jay Budoff, Natalie Marrero, George Thanassoulis, Wendy S. Post et al. · 2026 · Journal of the American Heart Association
  23. A practical guide to target trial emulation: connecting randomized trials and real-world data in cardiovascular research
    Ahlem Fourati, Marion Vergonjeanne, Thibaut Gellé, Julien Magné · 2026 · European Journal of Preventive Cardiology
  24. Joint association between FIB-4 index and advanced cardiovascular-kidney-metabolic syndrome with aortic valve calcification: a community cohort in China
    Yunteng Fang, Jiayi Shen, Junqiu Zhao, Xingwei Wei, Qiwen Huang, Guanyu Niu, Zhilin Wang, Haoxiang Xu, Xuan Wang, Yuesong Pan et al. · 2026 · Acta cardiologica. Supplementum
  25. Care of Patients With Apparently Asymptomatic Severe Aortic Valve Stenosis
    Mary Ann Williamson, Eli V. Gelfand · 2012 · Clinical Cardiology
  26. Effects of an Angiotensin II Type 1 Receptor Blocker on Aortic Valve Sclerosis in a Preclinical Model
    Zachary B. Armstrong, Derek R. Boughner, Colin P. Carruthers, Maria Drangova, Kem A. Rogers · 2014 · Canadian Journal of Cardiology
  27. Lipoprotein (a) is a risk factor of aortic valve calcification in patients with a risk of atherosclerosis
    Munkhtsetseg Tserensonom, Shusuke Yagi, Takayuki Ise, Yutaka Kawabata, Muneyuki Kadota, Tomoya Hara, Kenya Kusunos, Koji Yamaguchi, Hirotsugu Yamada, Takeshi Soeki et al. · 2023 · The Journal of Medical Investigation
  28. Genetic association of serum calcium, phosphate, vitamin D, parathyroid hormone, and FGF23 with the risk of aortic stenosis
    Qinghao Zhao, Wenchang Nie, Jiaming Dong, Bowen Zhang, Gongzheng Tang, Shenda Hong, Jian Liu · 2024 · npj Cardiovascular Health
  29. Development and external validation of a machine learning model for cardiac valve calcification early screening in dialysis patients: a multicenter study
    Xiaoxu Wang, Yinfang Li, Zixin Cao, Yunuo Li, Jingyuan Cao, Yao Wang, Min Li, Jing Zheng, Siqi Peng, Wen Shi et al. · 2025 · Renal Failure
  30. Outcome of Patients With Severe Aortic Stenosis and Normal Coronary Arteries Undergoing Transcatheter Aortic Valve Implantation
    Nazar Kuzo, Barbara Elisabeth Stähli, Ladina Erhart, Shehab Anwer, Matthias Schindler, Julia Kebernik, Sophie Mathys, Thi Dan Linh Nguyen‐Kim, Matthias Eberhard, Frank Thomas Ruschitzka et al. · 2021 · The American Journal of Cardiology
  31. Body Mass Index and Mortality from Nonrheumatic Aortic Valve Disease among Japanese Men and Women
    Masayuki Teramoto, Kazumasa Yamagishi, Renzhe Cui, Kokoro Shirai, Akiko Tamakoshi, Hiroyasu Iso · 2022 · Journal of Atherosclerosis and Thrombosis
  32. Obesity, Triglycerides, Remnant Cholesterol, and Other Causal Factors in Aortic Valve Stenosis: A Review
    Morten Kaltoft, Anne Langsted, Børge Grønne Nordestgaard · 2022 · CardioMetabolic Syndrome Journal
  33. Mouse Models of Calcific Aortic Valve Disease
    Bin Zhang, Grace Casaclang‐Verzosa, Jordan D. Miller · 2014 · Springer eBooks
  34. Valvular Heart Disease in Women
    Alian Aguila, Wassim I. Jawad, Khyati Baxi, Joel A. Strom · 2013 · Springer eBooks
  35. Notch Signaling in Congenital and Acquired Aortic Valve Disease
    Erik Fung, Masanori Aikaw · 2013 · InTech eBooks
  36. Treatment of older patients with aortic valve stenosis
    Sally Madden, John Hill · 2009 · Nursing Standard
  37. Nouveautés sur le rétrécissement valvulaire aortique
    Philippe Pîbarot, Jean Gaston Dumesnil, Patrick Mathieu · 2007 · médecine/sciences
  38. Slowing the progression of aortic stenosis
    Kameswari Maganti, Nalini Marie Rajamannan · 2008 · Current Treatment Options in Cardiovascular Medicine
  39. Role of 5-lipoxygenase pathway in the pathophysiology of the aortic stenosis
    Ramazan Akdemir, Mehmet Bülent Vatan · 2011 · Expert Review of Cardiovascular Therapy
  40. Intérêt du scanner dans la sténose aortique
    David Messika–Zeitoun · 2006 · Archives des Maladies du Coeur et des Vaisseaux - Pratique
  41. C-Reactive protein predicts severity, progression, and prognosis of asymptomatic aortic valve stenosis
    M.D. Cheitlin · 2009 · Yearbook of Cardiology
  42. [Epidemiology of valvular heart diseases in the adult].
    Bernard Iung · 2009 · PubMed
  43. [Research progress on pharmacotherapy of calcific aortic valve disease].
    Miaomiao Du, Gaigai Ma, Yuping Shi · 2016 · PubMed Central
  44. Innovations in Microscopic Imaging of Atherosclerosis and Valvular Disease
    Yu Nomura, Kengyeh K. Chu, Joseph A. Gardecki, Chen‐Hsin Sun, Linbo Liu, Eduardo Martínez‐Martínez, Elena Aïkawa, Guillermo J. Tearney · 2014 · Springer eBooks
  45. Valvular Heart Disease
    Sammy Elmariah, James L. Januzzi, James L. Januzzi, Aidan W. Flynn, Praveen Mehrotra, Igor F. Palacios, Igor F. Palacios · 2013 · Springer eBooks
  46. Aortic Stenosis
    Marie-Annick A Clavel, Nancy Côté, Philippe Pîbarot · 2019 · Springer eBooks
  47. Calcific Aortic Valve Disease: Imaging Studies and Therapeutic Interventions
    David M. Shavelle · 2007 · Journal of Investigative Medicine
  48. Aortic stenosis and the failing heart
    Federico M. Asch, Neil J. Weissman · 2006 · Expert Review of Cardiovascular Therapy
  49. Therapeutic Effect and Mechanism of Action of Abnormal Savda Munziq in Development of Degenerative Atherosclerotic Aortic Valve Disease
    Aisikaer Shabiti, Aili Aibibula, Aikeremu Tuerxun, Halmurat Wufuer · 2017 · Medical Science Monitor
  50. Osteoporosis and Aortic Stenosis: ‘Killing Two Birds with One Stone'?
    George A. Lazaros, Georgios Benetos, Konstantinos P. Toutouzas, Dimitris Tousoulis · 2015 · Cardiology
  51. Statins for women, elderly: Malpractice?
    Eddie Vos · 2007 · Nutrition Metabolism and Cardiovascular Diseases
  52. Statins for aortic stenosis? Still waiting for answers
    Catherine M Otto · 2007 · Nature Clinical Practice Cardiovascular Medicine
  53. The Mesozoic Flora of Graham Land . By T. G. Halle. Wissenschaftliche Ergebnisse d. Schwedischen Süd-polar-Expedition, 1901-1903. Bd. III., Lief. 14. Pp. 123. Pls. IX. Stockholm. 1913.
    Frank Hall Knowlton · 1913 · Science
  54. It was logical but was it the whole truth?
    S H Rahimtoola · 2013 · European Heart Journal
  55. Actualización clínica en valvulopatías
    Mohammed Waseem Akhter, Shahbudin H. Rahimtoola · 2007 · Revista Española de Cardiología
  56. OxPL
    Patricia J.M. Best, Nalini Marie Rajamannan · 2017 · Arteriosclerosis Thrombosis and Vascular Biology
  57. Rational Approaches Targeting the Prevention of Cardiovascular Calcification: The Evolving Field of Osteocardiology
    George A. Lazaros, Alexios S. Antonopoulos, Dimitris Tousoulis · 2018 · Cardiology
  58. Aortic valve and coronary 18F-sodium fluoride activity: a common cause?
    Rong Bing, Marc Richard Dweck · 2019 · Journal of Nuclear Cardiology
  59. Statins for aortic valve stenosis
    Luciana Thiago, Selma Rumiko Tsuji, Álvaro Nagib Atallah, Maria Eduarda dos Santos Puga, Aécio Flávio Teixeira de Góis, Orsine Valente · 2012 · Cochrane Database of Systematic Reviews
  60. Assessment of valvular function in over 47,000 people using deep learning-based flow measurements
    Shinwan Kany, Joel T Rämö, Cody R. Hou, Sean Joseph Jurgens, Victor Nauffal, Jonathan W. Cunningham, Emily S. Lau, Atul Janardhan Butte, Jennifer E. Ho, Jeffrey E. Olgin et al. · 2023 · medRxiv
  61. Medical Therapy for Aortic Stenosis
    Marc Richard Dweck, Neil J. Craig · 2024 · Journal of the American College of Cardiology
  62. Aortic Stenosis
    Nikolaus Jander, Jan Minners · 2017 · Elsevier eBooks
  63. Clinical Update on the Intersection of Lipoprotein(a) and Calcific Valve Disease
    Sarah C. Ashley, Eesha Kachhy, Kayla A. Brown, Meagan E. Prescott, Michelle D. Kelsey, Robert W. McGarrah, Neha Jadeja Pagidipati, Nishant P. Shah · 2025 · Current Cardiovascular Risk Reports
  64. Chronic Kidney Disease: Adding Yet Another Piece to the Puzzle in Aortic Stenosis
    Jordi S. Dahl, Rasmus Carter‐Storch · 2025 · Journal of the American Society of Echocardiography
  65. Clinical, Echocardiographic, and Socioeconomic Predictors of Progression and Outcomes in Patients With Moderate Aortic Stenosis
    Alex D’Amico, Paul J. Nona, Loren Wagner, Miguel R. Sotelo, Chris A. Rogers, Navin Nanda, Julian Booker, Efstathia Andrikopoulou · 2025 · Echocardiography
  66. Considerations in the Use of Mouse Models of Vascular and Valvular Calcification
    Jeffrey J. Hsu, Qian Li, Yin Tintut, Linda L. Demer · 2026 · Arteriosclerosis Thrombosis and Vascular Biology
  67. Medical therapies to prevent the development and progression of calcific aortic valve stenosis: a contemporary review
    William Courtney, J. A. Walker, Aindreas Dorai-Raj, Samer Arnous, Cormac T. O’Connor, David A. Playford, Abdul Rahman Ihdayhid, Carl Johann Schultz, Graham S. Hillis, Thomas John Kiernan · 2026 · Expert Review of Cardiovascular Therapy
  68. Moving beyond LDL cholesterol: apolipoprotein B and lipoprotein(a) for sex-specific risk assessment of aortic stenosis in the UK Biobank
    Wence Shi, Huiqiao Han, Jianqiu Pei, Cheng Ding, Younan Yao, Hongliang Zhang, Haiyan Xu, Y O N G J I Wu, Z C Li, Bin Zhang · 2026 · European Journal of Preventive Cardiology
  69. Immune Mechanisms of Heart Valve Development, Homeostasis, and Disease
    Brittany A. Gonzalez, Katherine E. Yutzey · 2026 · Arteriosclerosis Thrombosis and Vascular Biology
  70. Complement Component C4B Prioritization Through Drug‒Target Mendelian Randomization and Proteomic Analysis Reveals a Novel Therapeutic Target for Calcific Aortic Valve Stenosis
    Weijie Li, Ting Zhou, Songyuan Luo, J Z Chen, Zejia Wu, Wenhui Lin, Xiaolu Hu, Xinyue Yang, J Y Li, Zhaoyan Xu et al. · 2026 · Cardiovascular Drugs and Therapy
  71. Lipoprotein(a) and calcific aortic stenosis: from inherited risk marker to therapeutic target
    Francisco Epelde · 2026 · Frontiers in Medicine
  72. Contemporary Management of Aortic Stenosis: Timing of Intervention and Lifetime Valve Management
    Ottavia Cozzi, Thomas Pilgrim · 2026 · European Journal of Clinical Investigation
  73. Sodium–Glucose Cotransporter 2 Inhibitors in Valvular Heart Disease: Cardiovascular Benefit, Valve-Specific Effects, and Evidence Gaps—A Structured Narrative Review
    Maria Rada, Maria-Laura Craciun, Ana-Maria Pah, Gheorghe Stoichescu-Hogea, Daniela Gurguş, Milan Daniel Velimirovici, Dan Alexandru Surducan, Abdeldayem Mahmoud, Diana Uţu, Adina Cristiana Avram · 2026 · Journal of Clinical Medicine
  74. Effect of Ethanol Extract of Camellia Sinensis on Salmonella Typhi Infection in Adult Male Rats
    Mohammad Zahid Haider, Zesmin Fauzia Dewan, Md. Moniruzzaman Khan, Md. Enamul Kabir, M Shahabuddin, Mohsena Aktar, Joyashish Roy, Farjana Akter · 2022 · EAS Journal of Pharmacy and Pharmacology
  75. Considering alternatives to transcatheter heart valves for managing patients with severe aortic valve stenosis
    Hesham Elzomor, Ahmed Elkoumy, Sandeep Singh Hothi, Osama I.I. Soliman · 2024 · Expert Review of Medical Devices
  76. Hypercholesterolemia Familial: Early Cardiovascular Complications, Treatment Challenges, and the Fatal Consequences of Delayed Diagnosis: an in-Depth Case Study
    Mina Boutgourine, Hafssa Rouam, Mohammed El Jamili, Mustapha El Hattaoui · 2024 · Cardiology and Angiology An International Journal
  77. Opening Up the Future of Valvular Heart Disease
    David Messika–Zeitoun, Marino X. Labinaz, LAWRENCE S.W. LAU, Anahita Tavoosi, Tzlil Grinberg, Hassan Alfreidi, Mohammed K. Rashid, Andrew J. Mulloy, Pascal Thériault-Lauzier, Omar Abdel‐Razek et al. · 2025 · Canadian Journal of Cardiology
  78. Estenosis aórtica grave sintomática: ¿qué es grave, qué es sintomática y qué dicen las guías de práctica clínica sobre su manejo?
    Isidre Vilacosta, David Vivas, Javier López, J. Alberto San Román · 2015 · Revista Española de Cardiología Suplementos
  79. Valvular heart disease in women
    Kameswari Maganti, Vera H. Rigolin, Robert O. Bonow · 2008 · Current Cardiovascular Risk Reports
  80. FDG-PET-CT as a Biomarker for Aortic Valve Inflammation
    Gagandeep S. Gurm, Ahmed A Tawakol · 2011 · Current Cardiovascular Imaging Reports
  81. Medical treatments in aortic stenosis: Role of statins and angiotensin-converting enzyme inhibitors
    Zaklina Davicevic, Dragan Tavčiovski, Radomir Matunović · 2010 · Medicinski pregled
  82. Stress perfusion–fibrosis cardiac magnetic resonance detects early heart involvement in young asymptomatic, homozygous familial hyperlipidemia with normal routine non-invasive evaluation
    Sophie I. Mavrogeni, Konstantinos Bratis, Panagiota Papachristou, Ekaterini Giannakopoulou, Evangelos Karanasios, Genovefa D. Kolovou, Kees van Wijk, David J. Hautemann, Johan H. C. Reiber, George Papadopoulos · 2013 · International Journal of Cardiology
  83. Percutaneous and surgical treatment of aortic stenosis
    Daniel J O’Rourke, Bruce Wayne Andrus · 2006 · Expert Review of Cardiovascular Therapy
  84. A genetic advance: lipoprotein(a) in aortic stenosis
    Bobby Yanagawa, Nandini Gupta, Subodh Verma · 2013 · Clinical Lipidology
  85. LDL Cholesterol: ìBadî Cholesterol, or Bad Science?
    Anthony Colpo · 2005
  86. Valvular Heart Disease: Introduction, Clinical Pathogenesis, and Management
    Siri Kunchakarra, Jyothy J. Puthumana, Kameswari Maganti · 2015 · Springer eBooks
  87. Calcific Aortic Valve Disease: Osteoblast Differentiation in a Stem Cell Niche
    Nalini Marie Rajamannan · 2013 · Journal of Clinical & Experimental Cardiology
  88. What does the future hold for cholesteryl ester transfer protein inhibition?
    Benoît J. Arsenault, Marjorie Boyer, John J.P. Kastelein · 2015 · Current Opinion in Lipidology
  89. Basic Principles of Medical Therapy in the Patient with Valvular Heart Disease
    Catherine M Otto · 2009 · Elsevier eBooks
  90. Biomarkers of aortic valve stenosis: Should we rely on a single one?
    Inês Falcão‐Pires, Adelino Ferreira Leite-Moreira · 2016 · Revista Portuguesa de Cardiologia
  91. Chapter 21 Valvular Heart Disease
    Alec S. Vahanian, Bernard Iung, Luc Piérard, Robert A.E. Dion, John Pepper · 2009
  92. Place des marqueurs biologiques dans l’exploration du rétrécissement aortique calcifié
    Olivier Varennes, Isabelle Six, Romuald Mentaverri, Saı̈d Kamel · 2017 · Revue Francophone des Laboratoires
  93. Comprehensive Approach to Aortic Valve Disease
    Blase Anthony Carabello, Haziam Alwair, Rajasekhar Nekkanti · 2019 · Cardiovascular medicine
  94. Valvular Aortic Stenosis
    Judith Jane Tweedie, Mark S. Spence · 2017 · Elsevier eBooks
  95. Perioperative Management of Valvular Heart Disease
    Nathan H. Waldron, Martin Ingi Sigurdsson, Joseph P. Mathew · 2021 · Elsevier eBooks
  96. PET/CT Imaging of Inflammation and Calcification in CAVD: Clinical Studies
    Alex Thomas Vesey, Marc Richard Dweck, David Ernest Newby · 2014 · Springer eBooks
  97. Estenosis aórtica en el adulto
    David Messika–Zeitoun · 2020 · EMC - Tratado de Medicina
  98. Valvular Heart Disease
    Elisa Zaragoza‐Macias, Catherine M Otto · 2013 · Springer eBooks
  99. Multimodality imaging in aortic stenosis: new diagnostic and therapeutic frontiers
    Elena Ferrer‐Sistach, Albert Teis, Antoni Bayés‐Genís, Victoria Delgado · 2022 · Revista Española de Cardiología (English Edition)
  100. WITHDRAWN: Consensus on lipoprotein(a) of the Spanish Society of Arteriosclerosis. Literature review and recommendations for clinical practice
    Javier Delgado‐Lista, José María Mostaza, Teresa Arrobas-Velilla, Francisco Blanco‐Vaca, L. Masana, Juan Pedro‐Botet, Pablo Pérez‐Martínez, Fernando Civeira, José Ignacio Cuende, José Javier Gómez-Barrado et al. · 2024 · Clínica e Investigación en Arteriosclerosis (English Edition) · Retracted